Acurx Pharmaceuticals, Inc. (ACXP)
Data as of , from SEC Form 4 filings.
See up to 3 months of ACXP. The 7-day demo opens the 1M and 3M ranges and puts ACXP on your watchlist.
Start 7-day demoLatest ACXP insider trades
About Acurx Pharmaceuticals, Inc. (ACXP)
Acurx Pharmaceuticals, Inc. files with the SEC under CIK 0001736243 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site. It filed a registration statement with the SEC on 2 February 2026 and has not yet priced an offering.
ACXP Form 4 activity by transaction type, last 90 days
No Form 4 activity for ACXP in the last 90 days.
ACXP insider transactions (Form 4)
88 Form 4 filings on record, the earliest from Apr 22, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Carl Sailer - Director | Grant or award | Stock Option | 2,150 footnote F1 | $0.00 | - | |
| ||||||
| Jack H. Dean - Director | Grant or award | Stock Option | 2,150 footnote F1 | $0.00 | - | |
| ||||||
| James J. Donohue - Director | Grant or award | Stock Option | 2,150 footnote F1 | $0.00 | - | |
| ||||||
 Thomas L. Harrison - Director | Grant or award | Stock Option | 2,150 footnote F1 | $0.00 | - | |
| ||||||
| Joseph C. Scodari - Director | Grant or award | Stock Option | 2,150 footnote F1 | $0.00 | - | |
| ||||||
 Robert J. Deluccia - Director | Grant or award | Stock Option | 37,100 | $0.00 | - | |
| David P. Luci - Officer | Grant or award | Stock Option | 37,100 | $0.00 | - | |
 Robert G. Shawah - Officer | Grant or award | Stock Option | 25,900 | $0.00 | - | |
ACXP insider trading FAQ
What is the latest insider trade for ACXP?
Acurx Pharmaceuticals, Inc. (ACXP) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-04-22. The full record for ACXP runs to 8 Form 4 filings, the earliest from 2026-04-22. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ACXP stock?
No insider purchases of ACXP were filed in the last 90 days.
How many insiders are selling ACXP stock?
No insider sales of ACXP were filed in the last 90 days.
Where can I see ACXP SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ACXP Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
8The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Carl Sailer view on EDGAR
- - Jack H. Dean view on EDGAR
- - James J. Donohue view on EDGAR
- - Thomas L. Harrison view on EDGAR
- - Joseph C. Scodari view on EDGAR
- - Robert J. Deluccia view on EDGAR
- - David P. Luci view on EDGAR
- - Robert G. Shawah view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ACXP's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ACXP with a 7-day demo
- ACXP on your watchlist
- Every ACXP Form 4 filing on record
- Up to 3 months of ACXP price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
